Q&A – 2024 Nano-rare Patient Colloquium Recap Join [...] Andrew Andrew Serrano2024-12-18T13:04:00-04:00 Read More
GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases Collaboration provides GondolaBio access [...] Andrew Andrew Serrano2024-12-16T21:21:46-04:00 Read More
n-Lorem Foundation’s Nano-rare Patient Colloquium Draws More Than 750 attendees, Reinforcing Need for Treatment Options for People with Nano-rare Illnesses n-Lorem has made tremendous [...] Andrew Andrew Serrano2024-12-12T12:21:43-04:00 Read More
Best of the 2024 Nano-rare Patient Colloquium This [...] Andrew Andrew Serrano2024-12-04T12:08:29-04:00 Read More
n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End n-Lorem to share its [...] Andrew Andrew Serrano2024-10-29T17:48:00-04:00 Read More
Susannah’s Progress: Two Years of ASO Treatment with Dr. Jennifer Bain and Luke Rosen Andrew Andrew Serrano2024-10-16T11:10:26-04:00 Read More
n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations Article published in Nucleic [...] Andrew Andrew Serrano2024-12-16T20:03:25-04:00 Read More
Sneak Peek of the 2024 Nano-rare Patient Colloquium Brady Huggett interviews Stan Crooke Andrew Andrew Serrano2024-10-02T11:09:08-04:00 Read More
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations Crooke, S.T. Andrew Andrew Serrano2024-10-01T13:22:45-04:00 Read More